CMND
Clearmind Medicine Inc. - Common Shares (CMND)
$
97About Clearmind Medicine Inc. - Common Shares (CMND)
Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. It focuses on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize it as regulated medicines, foods, or supplements. The company was founded on July 18, 2017 and is headquartered in Vancouver, Canada.
Details
Daily high
$0.98
Daily low
$0.95
Price at open
$0.95
52 Week High
$2.30
52 Week Low
$0.85
Market cap
3.1M
Dividend yield
0.00%
Volume
40,432
Avg. volume
598,020
P/E ratio
-.74
Clearmind Medicine Inc. - Common Shares News
Details
Daily high
$0.98
Daily low
$0.95
Price at open
$0.95
52 Week High
$2.30
52 Week Low
$0.85
Market cap
3.1M
Dividend yield
0.00%
Volume
40,432
Avg. volume
598,020
P/E ratio
-.74